跳转至内容
Merck

112003

Sigma-Aldrich

马尿酸

98%

别名:

N-苯甲酰甘氨酸, 苯甲酰氨基乙酸

登录查看公司和协议定价


About This Item

线性分子式:
C6H5CONHCH2COOH
CAS号:
分子量:
179.17
Beilstein:
1073987
EC號碼:
MDL號碼:
分類程式碼代碼:
12352209
PubChem物質ID:
NACRES:
NA.25

product name

马尿酸, 98%

化驗

98%

形狀

powder, crystals or chunks

mp

187-191 °C (lit.)

應用

peptide synthesis

SMILES 字串

OC(=O)CNC(=O)c1ccccc1

InChI

1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)

InChI 密鑰

QIAFMBKCNZACKA-UHFFFAOYSA-N

基因資訊

正在寻找类似产品? 访问 产品对比指南

應用

马尿酸可用于研究细胞生物学、化学生物学、生物活性小分子、氨基酸衍生物、肽合成、化学合成和营养。马尿酸已被用于告知原花青素的代谢和尿排泄。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

H Ukai et al.
Occupational and environmental medicine, 51(8), 523-529 (1994-08-01)
Exposure monitoring by personal diffusive samplers, biological monitoring of toluene exposure by urinary hippuric acid determination, haematology, serum biochemistry for liver function, and a subjective symptom survey by questionnaire were conducted on 303 male solvent workers. They were exposed to
Yoshiharu Itoh et al.
Analytical and bioanalytical chemistry, 403(7), 1841-1850 (2012-03-27)
Cardiovascular disease (CVD) is prevalent in patients with chronic kidney disease (CKD). In hemodialysis (HD) patients, some protein-bound uremic toxins are considered to be associated with CVD. However, it is not yet known which uremic toxins are important in terms
Justin J J van der Hooft et al.
Analytical chemistry, 84(16), 7263-7271 (2012-07-26)
In dietary polyphenol exposure studies, annotation and identification of urinary metabolites present at low (micromolar) concentrations are major obstacles. To determine the biological activity of specific components, it is necessary to have the correct structures and the quantification of the
T Takada et al.
Scientific reports, 8(1), 11147-11147 (2018-07-26)
Chronic kidney disease (CKD) patients accumulate uremic toxins in the body, potentially require dialysis, and can eventually develop cardiovascular disease. CKD incidence has increased worldwide, and preventing CKD progression is one of the most important goals in clinical treatment. In
Kristin J Adolfsen et al.
Nature communications, 12(1), 6215-6215 (2021-10-30)
In phenylketonuria (PKU) patients, a genetic defect in the enzyme phenylalanine hydroxylase (PAH) leads to elevated systemic phenylalanine (Phe), which can result in severe neurological impairment. As a treatment for PKU, Escherichia coli Nissle (EcN) strain SYNB1618 was developed under

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门